zoledronic acid has been researched along with Arthritis, Rheumatoid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, SSSJ; Alzahrani, FM; Alzahrani, KJ; Halawani, IF; Janakiraman, V; Patil, S; Sudhan, M | 1 |
| Chen, B; Chen, F; Chen, J; Chen, X; Feng, Z; Huang, B; Kong, X; Li, J; Song, H; Tao, S; Wei, X; Yao, Q; You, T; Yu, H; Zhang, X; Zhao, F; Zheng, L; Zheng, Z | 1 |
| Gao, C; Gu, Y; Han, X; Li, S; Ouyang, G; Xiao, L; Xie, J; Zheng, L | 1 |
| Bank, I; Loebstein, R; Markovits, N | 1 |
| Bultink, IEM; Lems, WF; Raterman, HG | 1 |
| Ebbinghaus, M; Eitner, A; Hess, A; Hilger, I; Kamradt, T; Müller, S; Schaible, HG; Segond von Banchet, G; Wank, I | 1 |
| Fujimoto, Y; Muramatsu, K; Murayama, M; Nakata, E; Nomura, T; Ogane, S; Sekine, R; Shibahara, T; Shibui, T; Uchiyama, T; Watanabe, A; Yakushiji, T; Yamamoto, N | 1 |
| Chen, L; Curtis, JR; Delzell, E; Saag, KG; Xie, F; Yun, H | 1 |
| Hasei, T; Katsumi, H; Mozume, T; Sakane, T; Watanabe, T; Yamamoto, A; Yanagi, S | 1 |
| Aghaloo, TL; Bezouglaia, O; Cirelli, JA; Cunha, FQ; de Molon, RS; Dry, SM; Hsu, C; Pirih, FQ; Soundia, A; Tetradis, S | 1 |
| Berthelot, JM; Charrier, C; Heymann, D; Le Goff, B; Maugars, Y; Rédini, F; Soltner, E | 1 |
| Goldring, SR; Gravallese, EM | 1 |
| Conaghan, PG; Emery, P; Grainger, AJ; Jarrett, SJ; O'Connor, PJ; Ortmann, CE; Papanastasiou, P; Sloan, VS | 1 |
| Suzuki, Y | 1 |
| Grynpas, MD; Kandel, RA; Podworny, NV; Renlund, RC | 1 |
3 review(s) available for zoledronic acid and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Calcium; Denosumab; Diphosphonates; Exercise Therapy; Female; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Quality of Life; Teriparatide; Treatment Outcome; Vitamin D; Zoledronic Acid | 2019 |
Bisphosphonates: environmental protection for the joint?
Topics: Animals; Arthritis; Arthritis, Rheumatoid; Bone Resorption; Collagen; Diphosphonates; Disease Progression; Imidazoles; Osteoclasts; Zoledronic Acid | 2004 |
[Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis].
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Methotrexate; Osteoclasts; Zoledronic Acid | 2007 |
2 trial(s) available for zoledronic acid and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients.
Topics: Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Osteoporosis; Zoledronic Acid | 2019 |
Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Magnetic Resonance Imaging; Male; Middle Aged; Zoledronic Acid | 2006 |
10 other study(ies) available for zoledronic acid and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Rheumatoid arthritis treatment with zoledronic acid, a potentialinhibitorofGWAS-derived pharmacogenetics STAT3 and IL2 targets.
Topics: Arthritis, Rheumatoid; Humans; Interleukin-2; Molecular Docking Simulation; Pharmacogenetics; STAT3 Transcription Factor; Zoledronic Acid | 2023 |
A Dual-Targeted Metal-Organic Framework Based Nanoplatform for the Treatment of Rheumatoid Arthritis by Restoring the Macrophage Niche.
Topics: Arthritis, Rheumatoid; Bone Resorption; Delayed-Action Preparations; Humans; Macrophages; Metal-Organic Frameworks; Osteoclasts; Zoledronic Acid | 2023 |
Immune-mediated syndromes following intravenous bisphosphonate therapy.
Topics: Aged; Arthritis, Rheumatoid; Autoimmune Diseases; Crohn Disease; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Infusions, Intravenous; Male; Polymyalgia Rheumatica; Retrospective Studies; Syndrome; Zoledronic Acid | 2017 |
Contribution of Inflammation and Bone Destruction to Pain in Arthritis: A Study in Murine Glucose-6-Phosphate Isomerase-Induced Arthritis.
Topics: Activating Transcription Factor 3; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Bone Resorption; Cyclic AMP Response Element-Binding Protein; Glucose-6-Phosphate Isomerase; Hindlimb; Hyperalgesia; Inflammation; Mice; Pain; T-Lymphocytes, Regulatory; TRPV Cation Channels; Zoledronic Acid | 2019 |
Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Arthritis, Rheumatoid; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diabetes Complications; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Imidazoles; Infusions, Parenteral; Japan; Male; Middle Aged; Oral Surgical Procedures; Osteoporosis; Prostatic Neoplasms; Risedronic Acid; Treatment Outcome; Wound Healing; Zoledronic Acid | 2013 |
Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab.
Topics: Abatacept; Adalimumab; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Factors; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Hospitalization; Humans; Imidazoles; Immunoconjugates; Infections; Infliximab; Male; Medicare; Middle Aged; Osteoporosis; Proportional Hazards Models; Risk Factors; United States; Zoledronic Acid | 2015 |
Pharmacokinetic and therapeutic efficacy of intrapulmonary administration of zoledronate for the prevention of bone destruction in rheumatoid arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Bone and Bones; Bone Density Conservation Agents; Bronchoalveolar Lavage Fluid; Collagen; Creatinine; Diphosphonates; Disease Models, Animal; Drug Delivery Systems; Imidazoles; Lung; Male; Mice; Mice, Inbred DBA; Rats; Rats, Wistar; Zoledronic Acid | 2016 |
Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study.
Topics: Animals; Arthritis, Rheumatoid; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Disease Progression; Imaging, Three-Dimensional; Imidazoles; Male; Mandible; Maxilla; Mice, Inbred DBA; Severity of Illness Index; X-Ray Microtomography; Zoledronic Acid | 2016 |
A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis.
Topics: Absorptiometry, Photon; Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Bone and Bones; Diphosphonates; Drug Therapy, Combination; Female; Imidazoles; Immunohistochemistry; Methotrexate; Osteoclasts; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed; Zoledronic Acid | 2009 |
Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis.
Topics: Animals; Arthritis, Rheumatoid; Carrageenan; Cartilage, Articular; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Injections, Subcutaneous; Knee Joint; Osteochondritis; Rabbits; Reference Values; Synovial Membrane; Zoledronic Acid | 1999 |